Lista de obras - Antonio Drago - Dominio Público Uruguay

5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies

artículo científico publicado en 2007

A model to investigate SNPs' interaction in GWAS studies

artículo científico publicado en 2014

A molecular pathway analysis informs the genetic background at risk for schizophrenia

artículo científico publicado en 2014

A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment

artículo científico publicado en 2017

A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment

artículo científico publicado en 2014

A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia.

artículo científico publicado en 2017

AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment.

artículo científico publicado en 2012

CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients

artículo científico publicado en 2015

Corrigendum to “DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients” [Neurosci. Lett. 440 (2008) 150–154]

scholarly article published in Neuroscience Letters

DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy

artículo científico publicado en 2014

DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients

artículo científico publicado en 2008

Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D.

artículo científico publicado en 2012

Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder

artículo científico publicado en 2015

Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features

artículo científico publicado en 2009

Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment

artículo científico publicado en 2009

Erratum to: HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory

scholarly article published in European Journal of Clinical Pharmacology

Focus on HTR2C: A possible suggestion for genetic studies of complex disorders

artículo científico publicado en 2009

Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls

artículo científico publicado en 2015

Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients

artículo científico publicado en 2014

Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment.

artículo científico publicado en 2014

Genomewide interaction and enrichment analysis on antidepressant response

artículo científico publicado en 2013

Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol

article

HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory

artículo científico publicado en 2009

HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies

artículo científico publicado en 2007

Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis

artículo científico

Incomplete coverage of candidate genes: a poorly considered bias

artículo científico publicado en 2007

Insight gained from genome-wide interaction and enrichment analysis on weight gain during citalopram treatment.

artículo científico publicado en 2016

Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment

artículo científico publicado en 2009

Investigation of an epistastic effect between a set of TAAR6 and HSP-70 genes variations and major mood disorders

artículo científico publicado en 2010

Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment

artículo científico publicado en 2010

Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta).

artículo científico publicado en 2009

Mechanisms of antidepressant action: an integrated dopaminergic perspective

scientific article published on 11 March 2011

Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain

scientific article published on 14 November 2019

No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample

article

No association of a set of candidate genes on haloperidol side effects

artículo científico publicado en 2012

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

article

Pharmacogenetics of antidepressant response

artículo científico publicado en 2011

Pharmacogenetics of antidepressant response: an update

artículo científico publicado en 2009

Pharmacogenetics of antidepressants

artículo científico publicado en 2011

Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms

scientific article published on 07 May 2010

Pharmacogenomics of Depression

Sociodemographic and treatment related variables are poor predictors of haloperidol induced motor side effects

artículo científico publicado en 2010

Sociodemographic features predict antidepressant trajectories of response in diverse antidepressant pharmacotreatment environments: a comparison between the STAR*D study and an independent trial

artículo científico publicado en 2011

Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials

artículo científico publicado en 2010

Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia

artículo científico publicado en 2008

TAAR 6 and HSP-70 variations associated with bipolar disorder

artículo científico publicado en 2009

TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: an open label study.

artículo científico publicado en 2008

TAAR6 variations possibly associated with antidepressant response and suicidal behavior

artículo científico publicado en 2010

The 8th annual pharmacogenetics in psychiatry meeting report

artículo científico publicado en 2009

The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample

artículo científico publicado en 2011

The genetics of vascular incidents associated with second-generation antipsychotic administration

artículo científico

The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients

artículo científico publicado en 2009

The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades

artículo científico publicado en 2015

The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes

artículo científico publicado en 2011

The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes

artículo científico

Videoconferencing in psychiatry, a meta-analysis of assessment and treatment

artículo científico publicado en 2016

Lista de obras de Antonio Drago

5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies

A model to investigate SNPs' interaction in GWAS studies

A molecular pathway analysis informs the genetic background at risk for schizophrenia

A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment

A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment

A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia.

AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment.

CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients

Corrigendum to “DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients” [Neurosci. Lett. 440 (2008) 150–154]

DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy

DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients

Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D.

Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder

Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features

Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment

Erratum to: HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory

Focus on HTR2C: A possible suggestion for genetic studies of complex disorders

Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls

Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients

Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment.

Genomewide interaction and enrichment analysis on antidepressant response

Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol

HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory

HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies

Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis

Incomplete coverage of candidate genes: a poorly considered bias

Insight gained from genome-wide interaction and enrichment analysis on weight gain during citalopram treatment.

Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment

Investigation of an epistastic effect between a set of TAAR6 and HSP-70 genes variations and major mood disorders

Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment

Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta).

Mechanisms of antidepressant action: an integrated dopaminergic perspective

Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain

No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample

No association of a set of candidate genes on haloperidol side effects

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

Pharmacogenetics of antidepressant response

Pharmacogenetics of antidepressant response: an update

Pharmacogenetics of antidepressants

Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms

Pharmacogenomics of Depression

Sociodemographic and treatment related variables are poor predictors of haloperidol induced motor side effects

Sociodemographic features predict antidepressant trajectories of response in diverse antidepressant pharmacotreatment environments: a comparison between the STAR*D study and an independent trial

Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials

Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia

TAAR 6 and HSP-70 variations associated with bipolar disorder

TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: an open label study.

TAAR6 variations possibly associated with antidepressant response and suicidal behavior

The 8th annual pharmacogenetics in psychiatry meeting report

The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample

The genetics of vascular incidents associated with second-generation antipsychotic administration

The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients

The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades

The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes

The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes

Videoconferencing in psychiatry, a meta-analysis of assessment and treatment